About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Back to clinical trial search

RECRUITINGNANCT05477212

Evaluation of Gut Permeability in Patients Affected by Obesity and NAFLD: Influence of Ketogenic Diet.

This study is open label, with one arm only. In this study will be enrolled patients with obesity (BMI more than 30). Aim of the study is to determine the influence (if any) of a very low calorie keto...

Lead sponsor: Azienda Ospedaliera Specializzata in Gastroenterologia Saverio de Bellis•1 locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Contacts

Giovanni De Perogla, Prof

CONTACT

0804994635 [email protected]

Sponsors

Lead Sponsor

Azienda Ospedaliera Specializzata in Gastroenterologia Saverio de Bellis

Collaborators

Francesco Russo
Giuseppe, Riezzo
Michele, Linsalata
Antonella, Orlando
Benedetta, D Attoma
Laura, Prospero
Antonia, Ignazzi
Sara, De Nucci
Raffaele, Cozzolongo
Vito, Giannuzzi
Maria, De Angelis
Giusy Rita, Caponio
Oronzo, Milella
Gianluigi, Giannelli

Age

18 - 65 years

Sex

ALL

Healthy Volunteers

No

Inclusion Criteria

•1. BMI ≥ 30 Kg/m2 or abdominal circumference (waist) \>94 cm in men and \>80 cm in women (IDF criteria for the definition of abdominal obesity) with or without the features that characterize the metabolic syndrome
•2. Age range between 18 and 70 years, both sexes
•3. Diagnosis of hepatic steatosis, formulated on the basis of fibroscan \[CAP (controlled attenuation parameter) \> 238 dB/m(decibel/meter)\], and other recognized criteria (FLI - Fatty Liver Index , FIB-4 - Fibrosis-4 index, NFS - NAFLD fibrosis score).
•3. Treatment with any device, pharmacological or not, that can affect intestinal permeability and liver metabolism and, therefore, the presence of steatosis
•4. Pregnancy or lactation

Exclusion Criteria

•1. Normal and underweight subjects

Related studies

The Effects of Increasing Caloric Intake on Diet-Induced Thermogenesis and 24h Energy Expenditure

NCT05545306 · Obesity, Normal Physiology, and more

Visceral Adipose Tissue and Liver Changes Associated With Semaglutide in CKD

NCT07187830 · Chronic Kidney Disease in Type 2 Diabetes, Obesity & Overweight

A Study to See if an iPhone Weight Management App Can Help Promote Weight Loss in Adolescents and Young Adults After a Stem Cell Transplant

NCT04453072 · Obesity, Malignant Neoplasm

Can Pre-operative Lean Mass Predict Weight Loss After Roux-en-Y Gastric Bypass?

NCT07565051 · Morbid Obesity Requiring Bariatric Surgery

Pregnancy Exercise Mode Effect on Childhood Obesity

NCT04805502 · Pregnancy, Overweight and Obesity

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: October 2, 2024Terms

Trial snapshot

StatusRECRUITING

PhaseNA

Enrollment30

Start dateApr 2022

Last updatedOct 2, 2024

Condition

Permeability; Increased NAFLD Obesity

Locations shown

Irccs Saverio de Bellis

Castellana Grotte, BARI

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: October 2, 2024Data synced to Clareo: May 25, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions